Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ernst A Lien

Showing results (21-30 of 27) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 27 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasiaBernardo Bonanni, Davide Serrano, Sara Gandini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissueLine L Haugan Moi, Marianne Hauglid Flågeng, Sara Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancerPer E Lønning, Jürgen Geisler, Lars E Krag, et al.
Journal of the National Cancer Institute|June 5, 2003
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkersAndrea Decensi, Chris Robertson, Giuseppe Viale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal womenAndrea Decensi, Chris Robertson, Aliana Guerrieri-Gonzaga, et al.
Breast Cancer Research : BCR|November 30, 2017
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patientsThomas Helland, Nina Henne, Ersilia Bifulco, et al.
BMJ Open|April 29, 2022
Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) studyHåvard Søiland, Emiel A M Janssen, Thomas Helland, et al.
Pageof 3

Showing results (21-30 of 27) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 27 results.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 6, 2009
Randomized biomarker trial of anastrozole or low-dose tamoxifen or their combination in subjects with breast intraepithelial neoplasiaBernardo Bonanni, Davide Serrano, Sara Gandini, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 25, 2010
Effect of low-dose tamoxifen on steroid receptor coactivator 3/amplified in breast cancer 1 in normal and malignant human breast tissueLine L Haugan Moi, Marianne Hauglid Flågeng, Sara Gandini, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|June 29, 2005
Effects of exemestane administered for 2 years versus placebo on bone mineral density, bone biomarkers, and plasma lipids in patients with surgically resected early breast cancerPer E Lønning, Jürgen Geisler, Lars E Krag, et al.
Journal of the National Cancer Institute|June 5, 2003
A randomized trial of low-dose tamoxifen on breast cancer proliferation and blood estrogenic biomarkersAndrea Decensi, Chris Robertson, Giuseppe Viale, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|July 15, 2009
Randomized double-blind 2 x 2 trial of low-dose tamoxifen and fenretinide for breast cancer prevention in high-risk premenopausal womenAndrea Decensi, Chris Robertson, Aliana Guerrieri-Gonzaga, et al.
Breast Cancer Research : BCR|November 30, 2017
Serum concentrations of active tamoxifen metabolites predict long-term survival in adjuvantly treated breast cancer patientsThomas Helland, Nina Henne, Ersilia Bifulco, et al.
BMJ Open|April 29, 2022
Liquid biopsies and patient-reported outcome measures for integrative monitoring of patients with early-stage breast cancer: a study protocol for the longitudinal observational Prospective Breast Cancer Biobanking (PBCB) studyHåvard Søiland, Emiel A M Janssen, Thomas Helland, et al.
Pageof 3